Industries

Health Care

Moderna loses challenge to Arbutus patent on vaccine technology

Moderna loses challenge to Arbutus patent on vaccine technology

By: Jan Wolfe
Source: Reuters
Date of Publication: July 23rd, 2020
Shares of Moderna Inc fell nearly 10% after it lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma that poses a potential obstacle to Moderna’s efforts to develop next-generation vaccines, including a coronavirus vaccine.
Surging demand for medical equipment puts Philips on course for second-half recovery

Surging demand for medical equipment puts Philips on course for second-half recovery

By: Bart H. Meijer
Source: Reuters
Date of Publication: July 20th, 2020
Electrical equipment maker Philips said a recent surge in orders for scanners and other medical equipment should enable group sales and margins to rebound over the next six months from a slump in the second quarter.
Uber offers COVID-19 contact tracing help amid chaotic U.S. response

Uber offers COVID-19 contact tracing help amid chaotic U.S. response

By: Tina Bellon
Source: Reuters
Date of Publication: July 20th, 2020
Uber Technologies Inc has quietly launched a service to give public health officials quick access to data on drivers and riders presumed to have come into contact with someone infected with COVID-19, company officials told Reuters.
CVS Covid-19 Test Results Are Taking Longer Than Customers Have Been Told - WSJ

CVS Covid-19 Test Results Are Taking Longer Than Customers Have Been Told

By: Scott Patterson, Sarah Krouse and Sharon Terlep
Source: The Wall Street Journal
Date of Publication: July 17th, 2020
Testees complain about waiting more than 10 days as coronavirus cases surge in U.S.
DoorDash partners with Walgreens to deliver over-the-counter drugs and other health products

DoorDash partners with Walgreens to deliver over-the-counter drugs and other health products

By: Kevin Stankiewicz
Source: CNBC
Date of Publication: July 16th, 2020
DoorDash announced a partnership Thursday with Walgreens Boots Alliance to deliver over-the-counter medication and other products from the drugstore chain.
Demand For Abbott Labs Covid-19 Tests Surges Past 40 Million As Pandemic Cases Surge_Forbes

Demand For Abbott Labs Covid-19 Tests Surges Past 40 Million As Pandemic Cases Surge

By: Bruce Japsen
Source: Forbes
Date of Publication: July 16th, 2020
Abbott Laboratories said demand is surging for its portfolio of tests for the coronavirus strain Covid-19 as the pandemic triggers unprecedented need for its diagnostic products around the world.
Early data from Moderna's coronavirus vaccine sparks Wall Street hopes

Early data from Moderna's coronavirus vaccine sparks Wall Street hopes

By: Manas Mishra
Source: Reuters
Date of Publication: July 15th, 2020
Moderna Inc’s (MRNA.O) shares rose 17% on Wednesday after a small-scale study showed its experimental COVID-19 vaccine produced high levels of virus-killing antibodies, bolstering hopes the shot could prove effective in later stages of testing.
U.S. signs $450 million contract with Regeneron for COVID-19 therapy

U.S. signs $450 million contract with Regeneron for COVID-19 therapy

By: Manojna Maddipatla
Source: Reuters
Date of Publication: July 7th, 2020
The U.S. government signed a $450 million contract with Regeneron Pharmaceuticals Inc (REGN.O) for its potential COVID-19 antibody cocktail, the drugmaker said on Tuesday.
U.S. government awards Novavax $1.6 billion for coronavirus vaccine

U.S. government awards Novavax $1.6 billion for coronavirus vaccine

By: Julie Steenhuysen
Source: Reuters
Date of Publication: July 7th, 2020
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals

Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals

By: Sy Mukherjee
Source: Fortune
Date of Publication: June 22nd, 2020
Gilead won the first Food and Drug Administration (FDA) emergency authorization for a COVID-19 treatment in May. Now, the biotech giant says, it will soon begin clinical trials for a different version of the same experimental drug, remdesivir, which might make it easier to administer outside of a hospital or ICU wing.